This examine proposes that K2's high adverse outcome occurrence is because of, at the very least partially, to distinct JWH-018 metabolite action at the cannabinoid 1 receptor (CB1R), and implies that metabolites of most medicines, but not the carboxy metabolite, retain in vitro and in vivo activity at CB1Rs. The https://mam-220198642.blogofoto.com/62372038/new-step-by-step-map-for-synthetic-cannabinoids-eam2201